Stay updated with breaking news from Calculating Attenuation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phillips received clearance from FDA for its artificial intelligence MR platform that is used to detect cancerous tumors in the head and neck.
Investegate announcements from Royal Philips, Philips advances MR radiotherapy imaging and simulation for head and neck cancers
October 20, 2022 FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows MacroMedics' positioning